Orchasp Ltd

As of June 30, 2026, Orchasp Ltd carries a market capitalization of 635.91M, placing it among publicly traded companies globally. Its enterprise value stands at 635.91M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Orchasp Ltd has 319.55M shares outstanding.

As of June 30, 2026, Orchasp Ltd trades at a trailing price-to-earnings ratio of 81.38.

These figures are as of June 30, 2026. The EV/Sales ratio of 4.08 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 635.91M versus a market cap of 635.91M, with the gap driven by net debt and cash on the balance sheet.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 3.46M in revenue per employee across its workforce of 45.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Orchasp Ltd recorded an income tax benefit of -1.77M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 6.12M, leaving 7.90M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Orchasp Ltd's stock has declined approximately 68.14% over the past 52 weeks. The 50-day moving average sits at 1.36, while the 200-day moving average is 1.96.

Over the twelve months ended June 30, 2026, Orchasp Ltd generated 155.88M in revenue and converted that into 7.90M in net income, yielding earnings per share of 0.02. EBITDA reached -38.93M, while operating income came in at -39.35M.

Over the twelve months ended June 30, 2026, Orchasp Ltd posted a gross margin of -12.15, reflecting its pricing power and cost economics. The operating margin of -25.24 and net profit margin of 5.07 provide insight into operational efficiency.